Iron deficiency: an ominous sign in patients with systolic chronic heart failure

…, A Witkowska, J Nowak, O Hartmann… - European heart …, 2010 - academic.oup.com
Aims Beyond erythropoiesis, iron is involved in numerous biological processes crucial for
maintenance of homeostasis. Patients with chronic heart failure (CHF) are prone to develop …

Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial

…, G Terracciano, D Kremastinos, O Hartmann… - Journal of the American …, 2010 - jacc.org
Objectives : Our purpose was to assess the diagnostic utility of mid-regional pro–atrial natriuretic
peptide (MR-proANP) for the diagnosis of acute heart failure (AHF) and the prognostic …

Copeptin improves early diagnosis of acute myocardial infarction

…, E Lubos, D Peetz, J Kunde, O Hartmann… - Journal of the American …, 2010 - jacc.org
Objectives : Early identification of myocardial infarction in chest pain patients is crucial to
identify patients at risk and to maintain a fast treatment initiation. Background : The aim of the …

C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study

…, HL Hillege, J Struck, O Hartmann… - European heart …, 2009 - academic.oup.com
Aims The aim of the present study was to compare the prognostic value of a novel and
promising marker, copeptin, with B-type natriuretic peptide (BNP), and N-terminal pro-BNP (NT-…

Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure

…, P Rozentryt, A Witkowska, J Nowak, O Hartmann… - Journal of cardiac …, 2011 - Elsevier
BACKGROUND: Iron is an indispensable element of hemoglobin, myoglobin, and cytochromes,
and, beyond erythropoiesis, is involved in oxidative metabolism and cellular energetics. …

Cardiovascular and inflammatory biomarkers to predict short-and long-term survival in community-acquired pneumonia: Results from the German Competence …

…, S Ewig, S Giersdorf, O Hartmann… - American journal of …, 2010 - atsjournals.org
Rationale: Several new biomarkers are related to mortality in community-acquired pneumonia
(CAP). Objectives: Aim of this study was to compare new biomarkers for the prediction of …

Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study

…, G Terracciano, D Kremastinos, O Hartmann… - Circulation: heart …, 2011 - Am Heart Assoc
Background— In patients with heart failure (HF), increased arginine vasopressin concentrations
are associated with more severe disease, making arginine vasopressin an attractive …

Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients …

…, I Anand, AHB Wu, J Papassotiriou, O Hartmann… - Journal of the american …, 2013 - jacc.org
Objectives : The goal of this study was to demonstrate that copeptin levels <14 pmol/L allow
ruling out acute myocardial infarction (AMI) when used in combination with cardiac troponin I …

Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart …

…, J McCord, G Terracciano, O Hartmann… - European journal of …, 2012 - Wiley Online Library
Aims Biomarkers have proven their ability in the evaluation of cardiopulmonary diseases.
We investigated the utility of concentrations of the biomarker procalcitonin (PCT) alone and …

Efficacy, safety, and quality of life in a multicenter, randomized, placebo-controlled trial of low-dose peanut oral immunotherapy in children with peanut allergy

…, M Roeder, L Rosenfeld, O Hartmann… - The Journal of Allergy …, 2019 - Elsevier
Background Only 2 small placebo-controlled trials on peanut oral immunotherapy (OIT)
have been published. Objective We examined the efficacy, safety, immunologic parameters, …